Abstract
Indoleamine 2,3 dioxygenase (IDO) activity during pregnancy protects developing fetuses from maternal immune responses in CBA mice. We show here that fetal allografts were rejected only in mating combinations where paternally inherited tissue antigens elicited potent maternal T cell responses after exposure to IDO inhibitor. IDO inhibitor treatment triggered extensive inflammation at the maternal-fetal interface in susceptible mating combinations, which was characterized by complement deposition and hemorrhagic necrosis. Identical inflammatory responses occurred in B cell–deficient (RAG-1−/−) mothers that carried a monoclonal cohort of CD8+ T cells specific for a single paternally inherited fetal major histocompatibility complex antigen. Thus, fetal allograft rejection was accompanied by a unique form of inflammation that was characterized by T cell–dependent, antibody-independent activation of complement. In contrast, no inflammation, complement deposition or T cell infiltration was elicited when mice carrying syngeneic fetuses were exposed to IDO inhibitor. These data show that IDO activity protects the fetus by suppressing T cell–driven local inflammatory responses to fetal alloantigens.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mellor, A. L. & Munn, D. H. Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression. Annu. Rev. Immunol. 18, 367–391 (2000).
Brent, L. in A History of Transplantation Immunology, 403– 419 (Academic Press, London, 1997).
Hagmann, M. Embryos attacked by mom's natural defenses. Science 287, 408 (2000).
Medawar, P. B. Some immunological and endocrinological problems raised by evolution of viviparity in vertebrates. Symp. Soc. Exp. Biol. 7, 320–328 (1953).
Tafuri, A., Alferink, J., Moller, P., Hammerling, G. J. & Arnold, B. T cell awareness of paternal alloantigens during pregnancy . Science 270, 630–633 (1995).
Jiang, S. P. & Vacchio, M. S. Multiple mechanisms of peripheral T cell tolerance to the fetal “allograft”. J. Immunol. 160, 3086–3090 ( 1998).
Zhou, M. & Mellor, A. L. Expanded cohorts of maternal CD8+ T cells specific for paternal MHC class I accumulate during pregnancy . J. Reprod. Immunol. 40, 47– 62 (1998).
Lambert, N. C. et al. Persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity. J. Immunol. 164, 5545–5548 (2000).
Munn, D. H. et al. Prevention of allogeneic fetal rejection by tryptophan catabolism . Science 281, 1191–1193 (1998).
Cady, S. G. & Sono, M. 1-methyl-DL-tryptophan, β-(3-Benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and β-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase. Arch. Biochem. Biophys. 291, 326–333 (1991).
Yeoman, H. & Mellor, A. L. Tolerance and MHC restriction in transgenic mice expressing an MHC class I gene in erythroid cells. Int. Immunol. 4, 59–65 ( 1992).
Klein, J. Biology of the Mouse Histocompability-2 Complex (Springer-Verlag, New York, 1975).
Xu, C. et al. A critical role for murine complement regulator crry in fetomaternal tolerance. Science 287, 498– 501 (2000).
Munn, D. H. et al. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189, 1363– 1372 (1999).
Schwaeble, W. J. & Reid, K. B. Does properdin crosslink the cellular and the humoral immune response? Immunol. Today 20, 17–21 ( 1999).
Billingham, R. E. & Medawar, P. B. The technique of free skin grafting in mammals. J. Exp. Biol. 28, 385–401 (1951).
Acknowledgements
We thank D. McCool for technical assistance, A. Compton for administrative support and M. Litaker for statistical analysis. Supported by National Institutes of Health grants AI44219 to (A. L. M.), HL60137 (to D. H. M.) and AI40576 and AI44912 (to H. M.), the Medical College of Georgia Department of Medicine and the Carlos and Marguerite Mason Trust.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mellor, A., Sivakumar, J., Chandler, P. et al. Prevention of T cell–driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2, 64–68 (2001). https://doi.org/10.1038/83183
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/83183
This article is cited by
-
Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy
Journal of Hematology & Oncology (2023)
-
IDO1 is highly expressed in macrophages of patients in advanced tumour stages of oral squamous cell carcinoma
Journal of Cancer Research and Clinical Oncology (2023)
-
Association between endometrial indoleamine 2,3-dioxygenase expression level and pregnancy outcomes in women undergoing first in vitro fertilization treatment
BMC Pregnancy and Childbirth (2021)
-
Effect of the IDO Gene on Pregnancy in Mice with Recurrent Pregnancy Loss
Reproductive Sciences (2021)
-
Sexual dimorphism and the role of estrogen in the immune microenvironment of liver metastases
Nature Communications (2019)